Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10648studies shown

Showing 8,725-8,736 of 10,648

Drug study icon

CompletedNCT00877487

Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Drug study icon

TerminatedNCT00257192

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Colombia, Costa Rica, ...
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00257166

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolarity type I (Manic or Mixed)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT01095562

Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 20 Years to 55 Years

Countries: United States
Sponsor: AbbVie (prior sponsor, Abbott)
Condition: Schizophrenia

Drug study icon

CompletedNCT03260205

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 5 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Drug study icon

CompletedNCT02547428

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

CompletedNCT00199966

Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Medical College of Wisconsin
Condition: Bipolarity

Drug study icon

CompletedNCT00141050

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Novartis
Condition: ADHD

Drug study icon

TerminatedNCT01674010

Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, France, Canada, ...
Sponsor: OPKO Health, Inc.
Condition: Bipolarity

Device study icon

CompletedNCT01841970

Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDeviceOver 21 Years

Countries: United States
Sponsor: Medtronic - MITG
Condition: Bipolarity

Drug study icon

CompletedNCT01166425

Safety and Efficacy Study of Lithium for Pediatric Mania.

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 7 Years to 17 Years

Countries: United States
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Condition: Bipolarity

Drug study icon

CompletedNCT02895906

Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.